Drug Delivery System Market Outlook: Size, Share, Trends & Growth Analysis (2024-2029)
The market report presents a thorough analysis segmented by Type (Inhalation, Transdermal, Injectable, Others); by Device Type (Conventional, Advanced); by Distribution Channel (Hospital, Pharmacies, Retail Pharmacies); by Geography (North America, South America, Asia Pacific, Europe, The Middle East, Africa).
Outlook
- The drug delivery system market is estimated to be at USD 47,884.44 Mn in 2024 and is anticipated to reach USD 71,531.66 Mn in 2029.
- The drug delivery system market is registering a CAGR of 8.36% during the forecast period of 2024-2029.
- The global drug delivery system market is expanding rapidly, driven by its critical role in enhancing the efficacy and safety of therapeutics. Advancements in drug delivery technologies, such as nanotechnology, microneedles, and oral biologics, are transforming patient care.
Request a free sample.
Ecosystem
- The participants in the global drug delivery system industry lead the market through continuous investment in R&D and innovative product launches.
- These companies primarily focus on collaborations between pharmaceutical and technology companies, along with mergers and acquisitions, to maintain the competitive edge of the market.
- Several important entities in the drug delivery system market include Gerresheimer AG; Becton, Dickson, and Co.; Baxter International, Inc.; Kindeva Drug Delivery L.P.; Ypsomed AG; and others.
Ask for customization.
Findings
| Attributes | Values |
|---|---|
| Historical Period | 2018-2022 |
| Base Year | 2023 |
| Forecast Period | 2024-2029 |
| Market Size (2024) | USD 47,884.44 Mn |
| Market Size (2029) | USD 71,531.66 Mn |
| Growth Rate | 8.36% CAGR from 2024 to 2029 |
| Key Segments | Type (Inhalation, Transdermal, Injectable, Others); Device Type (Conventional, Advanced); Distribution Channel (Hospital, Pharmacies, Retail Pharmacies); Geography (North America, South America, Asia Pacific, Europe, The Middle East, Africa) |
| Key Vendors | Gerresheimer AG; Becton, Dickson, and Co.; Baxter International, Inc.; Kindeva Drug Delivery L.P.; Ypsomed AG |
| Key Countries | The US; Canada; Brazil; China; India; Japan; The UK; Germany; Russia; Italy; France; Spain; South Africa |
| Largest Market | North America |
Get a free quote.
Trends
- Wearable Drug Delivery Systems: Wearable drug delivery devices are gaining traction, offering patients real-time monitoring and controlled administration. In 2023, Medtronic introduced a wearable patch pump designed for continuous subcutaneous delivery of pain management drugs, showcasing advancements in wearable technology.
- Focus on Nanotechnology: Nanotechnology is emerging as a transformative tool in targeted drug delivery. In 2023, BIND Therapeutics developed a nanoparticle-based system to deliver cancer drugs directly to tumor sites, reducing side effects and improving therapeutic outcomes.
- Personalized Gene Delivery Systems: Drug delivery systems are becoming integral to personalized medicine, especially with the rise of gene and cell therapies. In 2023, Pfizer partnered with Beam Therapeutics to create gene-editing therapies that require precision delivery technologies to treat rare genetic disorders.
Speak to analyst.
Catalysts
- Prevalence of Chronic Diseases: The rising prevalence of chronic diseases such as diabetes, cancer, and cardiovascular diseases is a major driver for advanced drug delivery systems. In 2023, the World Health Organization reported that over 1.3 billion people globally suffer from chronic conditions, boosting demand for targeted and efficient drug delivery technologies.
- Adoption of Self-Administration: The shift towards self-administration of drugs is fueling demand for user-friendly delivery systems. In 2023, Novo Nordisk launched an updated pre-filled injection device for self-administration of diabetes medication, emphasizing convenience and patient autonomy.
- Demand for Injectable Biologics: The increasing use of injectable biologics for treating autoimmune diseases and cancers is driving the need for advanced injection systems. In 2023, Roche introduced a new auto-injector for the self-administration of biologics, addressing the growing demand for injectable therapies in personalized medicine.
Inquire before buying.
Restraints
- High Development Costs: Developing new drug delivery systems is expensive, with significant investments required for R&D, testing, and manufacturing. In 2023, AstraZeneca reported spending over USD 600 million on the development of its novel inhalable drug delivery platform for respiratory conditions.
- Complexity in Manufacturing: Manufacturing sophisticated drug delivery systems, such as nano-encapsulation or biologic delivery devices, poses technical challenges. In 2023, Gilead Sciences faced production delays with its nanoparticle-based drug delivery system due to issues scaling up manufacturing.
- Regulatory Hurdles: The regulatory landscape for drug delivery systems is complex, with stringent safety and efficacy standards that can delay approvals. In 2023, GlaxoSmithKline faced setbacks in the approval process for its microneedle patch for vaccine delivery due to safety concerns raised by regulators.
Personalize this research.
Hotspot
Explore purchase options.
Table of Contents
| 1.       Introduction 1.1.    Research Methodology 1.2.    Scope of the Study 2.       Market Overview / Executive Summary 2.1.    Global Drug Delivery System Market (2018 – 2022) 2.2.    Global Drug Delivery System Market (2023 – 2029) 3.       Market Segmentation 3.1.    Global Drug Delivery System Market by Type 3.1.1. Inhalation 3.1.2. Transdermal 3.1.3. Injectable 3.1.4. Others 3.2.    Global Drug Delivery System Market by Device Type 3.2.1. Conventional 3.2.2. Advanced 3.3.    Global Drug Delivery System Market by Distribution Channel 3.3.1. Hospital 3.3.2. Pharmacies 3.3.3. Retail Pharmacies 4.       Regional Segmentation 4.1.    North America 4.1.1. The US 4.1.2. Canada 4.1.3. Mexico 4.2.    South America 4.2.1. Brazil 4.2.2. Argentina 4.2.3. Colombia 4.2.4. Chile 4.2.5. Rest of South America 4.3.    Asia Pacific 4.3.1. China 4.3.2. India 4.3.3. Japan 4.3.4. South Korea 4.3.5. Rest of Asia Pacific 4.4.    Europe 4.4.1. The UK 4.4.2. Germany 4.4.3. Italy 4.4.4. France 4.4.5. Spain 4.4.6. Rest of Europe 4.5.    The Middle East 4.5.1. Turkey 4.5.2. UAE 4.5.3. Saudi Arabia 4.5.4. Rest of the Middle East 4.6.    Africa 4.6.1. Egypt 4.6.2. South Africa 4.6.3. Rest of Africa 5.       Value Chain Analysis of the Global Drug Delivery System Market 6.       Porter Five Forces Analysis 6.1.    Threats of New Entrants 6.2.    Threats of Substitutes 6.3.    Bargaining Power of Buyers 6.4.    Bargaining Power of Suppliers 6.5.    Competition in the Industry 7.       Trends, Drivers and Challenges Analysis 7.1.    Market Trends 7.1.1.    Market Trend 1 7.1.2.    Market Trend 2 7.1.3.    Market Trend 3 7.2.    Market Drivers 7.2.1.    Market Driver 1 7.2.2.    Market Driver 2 7.2.3.    Market Driver 3 7.3.    Market Challenges 7.3.1.    Market Challenge 1 7.3.2.    Market Challenge 2 7.3.3.    Market Challenge 3 8.       Opportunities Analysis 8.1.    Market Opportunity 1 8.2.    Market Opportunity 2 8.3.    Market Opportunity 3 9.       Competitive Landscape 9.1.    Gerresheimer AG 9.2.    Becton, Dickson, and Co. 9.3.    Baxter International, Inc. 9.4.    Kindeva Drug Delivery L.P. 9.5.    Ypsomed AG 9.6.    Company 6 9.7.    Company 7 9.8.    Company 8 9.9.    Company 9 9.10.  Company 10 |
Know the research methodology.
Drug Delivery System Market – FAQs
1. What is the current size of the drug delivery system market?
Ans. In 2024, the drug delivery system market size is $47,884.44 Mn.
2. Who are the major vendors in the drug delivery system market?
Ans. The major vendors in the drug delivery system market are Gerresheimer AG; Becton, Dickson, and Co.; Baxter International, Inc.; Kindeva Drug Delivery L.P.; Ypsomed AG.
3. Which segments are covered under the drug delivery system market segments analysis?
Ans. The drug delivery system market report offers in-depth insights into Type, Device Type, Distribution Channel, and Geography.